A global real estate investor's recent $102 million bet on the Bay Area's ongoing biotech boom appears to be paying off after landing a sizable lease to help fill some of its recently acquired life science campus space.

A global real estate investor's recent $102 million bet on the Bay Area's ongoing biotech boom appears to be paying off after landing a sizable lease to help fill some of its recently acquired life science campus space.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In